Shortage of (20MMOL/L) Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage is affecting (20MMOL/L) Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP, with no manufacturers or reasons specified in the source.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 7, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP.
Shortage of (20MMOL/L) Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection
What's in Shortage
The drug in shortage is the generic name (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP. No brand names are provided. The dosage form is an injection, and the current status is active.
Which Manufacturers Are Affected
No manufacturers are listed in the source data, so their availability status is unknown.
Why There's a Shortage
No specific reason was given for this shortage.
What Patients Should Do
Patients should talk to their pharmacist about the availability of this medication and consult their healthcare provider for guidance. Do not make any changes without professional advice. Remember, patients should always consult their healthcare provider for personalized recommendations.
Source
This information is from the FDA Drug Shortages Database.
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (927 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.